Atrial fibrillation in the elderly
Atrial fibrillation (AF) is the most common arrhythmia in older adults with a prevalence of 9 % in adults aged 80 years or older. AF patients have a five times greater risk of developing stroke than the general population. Using anticoagulants for stroke prevention in the elderly becomes a challenge...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84880829184&partnerID=40&md5=ae69986b78432b1304f2911c609fbc0f http://cmuir.cmu.ac.th/handle/6653943832/4149 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
id |
th-cmuir.6653943832-4149 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-41492014-08-30T02:35:43Z Atrial fibrillation in the elderly Nantsupawat T. Nugent K. Phrommintikul A. Atrial fibrillation (AF) is the most common arrhythmia in older adults with a prevalence of 9 % in adults aged 80 years or older. AF patients have a five times greater risk of developing stroke than the general population. Using anticoagulants for stroke prevention in the elderly becomes a challenge because both stroke and bleeding complications increase with age. CHA2DS 2-VASc and HAS-BLED scores are currently used as stroke and bleeding risk evaluations. When the HAS-BLED score is 3 or higher, caution and efforts to correct reversible risk factors are advised. Regardless of the HAS-BLED score, warfarin or novel oral anticoagulants are a IIa recommendation for CHA 2DS2-VASc of 1, except for a score of 1 for females, and a IA recommendation for the score of 2 or higher. Aspirin is no longer recommended for AF thromboprophylaxis. In an elderly patient, lenient rate control is preferred over rhythm control owing to fewer adverse drugs effects and hospitalizations. When rhythm control is needed, dronedarone is a new antiarrhythmic drug that can be considered in patients who have paroxysmal AF and no history of heart failure. Although less efficacious than amiodarone, dronedarone has a fewer thyroid, neurologic, dermatologic, and ocular side effects than amiodarone. © 2013 Springer International Publishing Switzerland. 2014-08-30T02:35:43Z 2014-08-30T02:35:43Z 2013 Article 1170229X 10.1007/s40266-013-0094-8 23709402 DRAGE http://www.scopus.com/inward/record.url?eid=2-s2.0-84880829184&partnerID=40&md5=ae69986b78432b1304f2911c609fbc0f http://cmuir.cmu.ac.th/handle/6653943832/4149 English |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
language |
English |
description |
Atrial fibrillation (AF) is the most common arrhythmia in older adults with a prevalence of 9 % in adults aged 80 years or older. AF patients have a five times greater risk of developing stroke than the general population. Using anticoagulants for stroke prevention in the elderly becomes a challenge because both stroke and bleeding complications increase with age. CHA2DS 2-VASc and HAS-BLED scores are currently used as stroke and bleeding risk evaluations. When the HAS-BLED score is 3 or higher, caution and efforts to correct reversible risk factors are advised. Regardless of the HAS-BLED score, warfarin or novel oral anticoagulants are a IIa recommendation for CHA 2DS2-VASc of 1, except for a score of 1 for females, and a IA recommendation for the score of 2 or higher. Aspirin is no longer recommended for AF thromboprophylaxis. In an elderly patient, lenient rate control is preferred over rhythm control owing to fewer adverse drugs effects and hospitalizations. When rhythm control is needed, dronedarone is a new antiarrhythmic drug that can be considered in patients who have paroxysmal AF and no history of heart failure. Although less efficacious than amiodarone, dronedarone has a fewer thyroid, neurologic, dermatologic, and ocular side effects than amiodarone. © 2013 Springer International Publishing Switzerland. |
format |
Article |
author |
Nantsupawat T. Nugent K. Phrommintikul A. |
spellingShingle |
Nantsupawat T. Nugent K. Phrommintikul A. Atrial fibrillation in the elderly |
author_facet |
Nantsupawat T. Nugent K. Phrommintikul A. |
author_sort |
Nantsupawat T. |
title |
Atrial fibrillation in the elderly |
title_short |
Atrial fibrillation in the elderly |
title_full |
Atrial fibrillation in the elderly |
title_fullStr |
Atrial fibrillation in the elderly |
title_full_unstemmed |
Atrial fibrillation in the elderly |
title_sort |
atrial fibrillation in the elderly |
publishDate |
2014 |
url |
http://www.scopus.com/inward/record.url?eid=2-s2.0-84880829184&partnerID=40&md5=ae69986b78432b1304f2911c609fbc0f http://cmuir.cmu.ac.th/handle/6653943832/4149 |
_version_ |
1681420182947364864 |